
Alzheimer’s disease has far-reaching impact on individuals, caregivers, families and society. Learn how Roche is tackling this looming global crisis.
moreAlzheimer's disease is a progressive brain disease characterised by a decline in memory, language and other thinking skills, as well as changes in mood and behaviour. Our goal is to change how the disease affects the brain - not just treat symptoms.
Alzheimer’s disease has far-reaching impact on individuals, caregivers, families and society. Learn how Roche is tackling this looming global crisis.
moreAlzheimer’s disease is one of our biggest global challenges, but every day we are growing our knowledge of this disease in order to find answers.
Downloads: Download
Over 50 million people worldwide live with dementia. By 2050, it is expected that this number will grow to more than 150 million.
Diagnostic certainty contributes to the search for effective treatment
moreBiomarkers play a crucial role in medical research; find out what they are and how they're used in Alzheimer's disease.
moreCaring for people with Alzheimer’s disease has a huge economic and emotional impact. Learn about the intangible costs and Freeha’s experience with her father.
more